Canaccord Genuity Maintains a 'Buy' on Laboratory Corporation (LH); Q2 Preview: Successful Commercial Lab Business
Tweet Send to a FriendGet Alerts LH Hot Sheet
Price: $100.94 +0.31%
Rating Summary:
4 Buy, 18 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 28 | New: 13
Rating Summary:
4 Buy, 18 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 28 | New: 13
Trade LH Now!
Canaccord Genuity maintains a 'Buy' on Laboratory Corporation of America (NYSE: LH) price target of $100.00.
Analyst, Jeffrey Frelick, said, "We expect LH to report Q2 sales of $1,470M (+4%), above consensus of $1,441M, and Adj. EPS of $1.78 (+9%), in line with consensus of $1.77."
"We have a BUY rating on LH as LabCorp succeeds on what we believe are the keys to a successful commercial lab business: price, volume, and efficiencies. As the low-cost lab provider, we think that LH does not have to concede on price to win business. We also think that LH has a leading management team in the industry. In our view, LH has done a better job of making strategic acquisitions than its large competitor, Quest Diagnostics (NYSE: DGX)."
For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.
Shares of Laboratory Corporation of America closed at $93.14 yesterday, with a 52 week range of $74.57-$97.81.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jeffrey Frelick, said, "We expect LH to report Q2 sales of $1,470M (+4%), above consensus of $1,441M, and Adj. EPS of $1.78 (+9%), in line with consensus of $1.77."
"We have a BUY rating on LH as LabCorp succeeds on what we believe are the keys to a successful commercial lab business: price, volume, and efficiencies. As the low-cost lab provider, we think that LH does not have to concede on price to win business. We also think that LH has a leading management team in the industry. In our view, LH has done a better job of making strategic acquisitions than its large competitor, Quest Diagnostics (NYSE: DGX)."
For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.
Shares of Laboratory Corporation of America closed at $93.14 yesterday, with a 52 week range of $74.57-$97.81.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
- Goldman Sachs Downgrades InterXion Holding (INXN) to Neutral
- Deutsche Bank Raises PT on NetApp (NTAP) to $48
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
